EurekAlert! InContext Modules

Public Release: 27-Mar-2012

Malaria Journal
Malaria prevention saves children’s lives
Malaria continues to be a major disease worldwide, but while funding projects are working hard to improve malaria prevention it is difficult to measure how effective these interventions are. New research published in BioMed Central's open access journal Malaria Journal has used a Lives Saved Tool model to show that the increase in funding for the prevention of malaria has prevented 850,000 child deaths in the decade between 2001 and 2010 across Africa.

Public Release: 27-Mar-2012

PLOS Medicine
IPTi in co-endemic falciparum and vivax malaria
A three-arm randomized trial conducted by Ivo Mueller of the Papua New Guinea Institute of Medical Research, Madang, Papua New Guinea, and colleagues among infants in Papua New Guinea estimates the preventive effect against malaria episodes of intermittent preventive treatment, in an area where children are exposed to both falciparum and vivax malaria.

Public Release: 26-Mar-2012

International Journal of Health Services
US economic woes ripple all the way to Latin America, U-M study shows
It's difficult to imagine a factory closing in Michigan or pay cuts for restaurant workers in Iowa having an impact on the health care of someone in rural Honduras but this study suggest that economic woes in the US ripple across the globe.

University of Michigan School of Public Health Global Health Summer Internship Program, Michigan Diabetes Research and Training Center, Michigan Institute for Clinical and Health Research

Public Release: 23-Mar-2012
UN hits water target, but 1.8 billion people still drinking unsafe water, study shows
Recent widespread news coverage heralded the success of a United Nations' goal of greatly improving access to safe drinking water around the world.

Public Release: 22-Mar-2012
UNC part of new US effort to tackle critical global water problems
Water experts from the University of North Carolina at Chapel Hill are among the key members of a new initiative announced Thursday (March 22) by US Secretary of State Hillary Rodham Clinton that aims to solve water problems around the globe.

Public Release: 22-Mar-2012
Introducing birth control in mosquitoes
Female mosquitoes require energy for their egg development, which they acquire from vertebrate blood. But by sucking on blood, they become vectors of numerous disease pathogens of human and domestic animals. Now a research team led by Alexander Raikhel, a distinguished professor of entomology at the University of California, Riverside, has received a five-year $2.8 million grant from the National Institutes of Health to study how birth control can be introduced in mosquitoes.

National Institutes of Health

Public Release: 22-Mar-2012
Montreal researchers repel mortality in Malian mothers
Researchers identify principal causes of death of women in Mali as they carry or give birth to their baby.

Public Release: 21-Mar-2012
Canada Gairdner Wightman Award honors U of S professor emeritus and former VIDO director
University of Saskatchewan professor emeritus Lorne Babiuk has been awarded the prestigious Canada Gairdner Wightman Award in recognition of his accomplishments over three decades that include leading the U of S Vaccine and Infectious Disease Organization to become a world center for vaccine research, training and development.

Gairdner Foundation

Public Release: 20-Mar-2012
Young researcher taking fight against global killer to the next level in Vietnam
An Australian scientist will bring effective screening for tuberculosis a step closer with his latest study in Vietnam -- where he now lives and works.

Australian Government

Public Release: 20-Mar-2012
Leading air pollution experts awarded prestigious 2012 Tyler Environmental Prize
The Tyler Prize for Environmental Achievement honors two experts on air pollution with the 2012 Tyler Prize for their work to advance the scientific understanding of air pollution, and develop solutions to reduce the danger to human health and the impact on climate change.

Public Release: 20-Mar-2012

Tuberculosis
New vaccine strategy to advance solutions for tuberculosis
Against a backdrop of growing concern about the impact of tuberculosis on children, top scientific experts today published a global plan of action for developing the vaccines that are seen as critical to eliminating the disease. Published today in a special issue of the journal, Tuberculosis, the strategic blueprint for the TB vaccine field, represents consensus reached by the TB vaccine community.

Contact: Erna Balk-Spruit
erna.balk@tbvi.eu
01-131-320-277-552
Stop TB Partnership Working Group on New Vaccines

Public Release: 19-Mar-2012
TB Alliance launches combination drug trial, establishes new pathway to TB and MDR-TB treatment
In an ambitious effort to stem the dangerous tide of tuberculosis (TB) and deadly drug-resistant TB around the world, TB Alliance today announced that it has launched a first-of-its-kind clinical trial to test a novel drug combination -- in both patients who have TB, and those who have multidrug-resistant TB (MDR-TB).

Public Release: 16-Mar-2012

EMBO Reports
Exposure to antibiotics linked to severity of allergic asthma: UBC research
Widely used antibiotics may increase incidence and severity of allergic asthma in early life, according to a University of British Columbia study.

Canadian Institutes of Health Research, Genome British Columbia, AllerGen NCE

Public Release: 15-Mar-2012

Cell
Researcher watches the start of his own disease with unprecedented detail
These days, most of us don't head to the doctor until we are already ill. What if you could see disease approaching just as it starts to head your way? A study in a special March 16th issue of Cell focused on human biology shows that this futuristic notion is already in reach.

Public Release: 14-Mar-2012

EMBO Molecular Medicine
Breakthroughs in Chikungunya research from A*STAR spell new hope for better treatment and protection
Researchers discovered a direct biomarker which serves as an early and accurate prognosis of patients who have a higher risk of the more severe form of Chikungunya fever. The team also uncovered a new experimental vaccine that raises hope for an effective Chikungunya vaccine that can offer protection against the virus in the event of an outbreak.

Agency for Science, Technology and Research

Public Release: 14-Mar-2012
Award to Aeras boosts historic hunt for new TB vaccines, as drug resistance proliferates
Aeras announces today the receipt of a grant by the Bill & Melinda Gates Foundation of up to US $220 million over five years, placing it at the forefront of a global scientific initiative aimed at developing safe, effective vaccines against tuberculosis, a disease that infects two billion people worldwide. One of the world's largest not-for-profit biotechs, Aeras, is developing modern vaccines to combat TB against the backdrop of a significant increase in drug-resistant strains.

Bill and Melinda Gates Foundation

Public Release: 13-Mar-2012
UC Riverside alumna receives high honor in genetics
Stephanie Turner Chen, a University of California, Riverside, alumna, has received the prestigious Larry Sandler Memorial Award given by the Genetics Society of America to the most outstanding Ph.D. dissertation of the year in Drosophila genetics. Turner Chen received the award last week at the 53rd Annual Drosophila Research Conference, Chicago. At UC Riverside, Turner Chen worked on the detection of carbon dioxide in the fruit fly and the mosquito.

Genetics Society of America

Public Release: 13-Mar-2012

Cochrane Library
Text messages help HIV patients stick to antiretroviral drug therapy
Mobile phones could play a valuable role in helping HIV patients to take their medication every day, according to a new Cochrane Systematic Review. The researchers found that patients were less likely to miss doses if they were sent weekly mobile phone text message reminders.

Public Release: 12-Mar-2012
DNDi secures €2 million Strategic Translation Award from Wellcome Trust to develop a new drug against Chagas disease
The Drugs for Neglected Diseases initiative has received a €2 million Strategic Translation Award from the Wellcome Trust to develop the azole compound E1224, a promising drug to treat Chagas disease being tested in adult patients in Bolivia. The award, the first that DNDi has received from the Wellcome Trust, will take the project to the end of Phase II clinical trials.

Wellcome Trust

Public Release: 8-Mar-2012

Clinical Infectious Diseases
7-country study examining the causes of childhood pneumonia outlined
The scientific journal Clinical Infectious Diseases has released its March Special Supplement focusing entirely on the research design of and pilot data from the Pneumonia Etiology Research for Child Health Project, which seeks to identify the causes of pneumonia among the world's most vulnerable populations.

Public Release: 8-Mar-2012
IDRI quest for leprosy vaccine closer to reality with help of million dollar grant
The Infectious Disease Research Institute has been awarded a $1 million grant from Renaissance Health Service Corporation and its Research and Data Institute, as the founding sponsor of IDRI's efforts to eliminate the disease of leprosy. The funding will support IDRI's development of a diagnostic to identify early infection of the disease, as well as an effective vaccine to provide long-term protection to those who are most at risk.

Renaissance Health Service Corporation Research and Data Institute

Public Release: 7-Mar-2012

New England Journal of Medicine
Commonly used dementia drugs can help more patients with Alzheimer's
The dementia drug donepezil (Aricept), already widely used to treat mild to moderate Alzheimer's disease, can also help in moderate to severe patients, according to a report funded by the UK Medical Research Council and the Alzheimer's Society. The study suggests that extending treatment to this group could help treat twice as many sufferers worldwide. Encouragingly, the drug has greater positive benefits for patients more severely affected than for those in the earlier stages of dementia.

Medical Research Council, Alzheimer's Society

Public Release: 6-Mar-2012
NIH-funded study defines treatment window for HIV+ children infected at birth
HIV-positive children older than 1 year who were treated after showing moderate HIV-related symptoms did not experience greater cognitive or behavior problems compared to peers treated when signs of their infection were still mild, according to a study funded by the National Institutes of Health.

National Institutes of Health

Public Release: 1-Mar-2012

Nature
Mayo researchers provide atomic view of a histone chaperone
Mayo Clinic researchers have gained insights into the function of a member of a family of specialized proteins called histone chaperones.

Public Release: 1-Mar-2012

HIV in Europe Conference
New indicator diseases reveal hidden HIV
An international study under the leadership of the HIV in Europe initiative has now revealed that a number of diseases, including herpes zoster and certain forms of cancer, should be on the list of indicators for having HIV -- and thus serve to prompt health care professionals to suggest an HIV-test to their patients. The new results and guidelines are to be debated at a major international HIV conference in Copenhagen on March 19-20.


			HOME DISCLAIMER PRIVACY POLICY TERMS & CONDITIONS CONTACT US TOP Copyright ©2012 by AAAS, the science society.